We are thrilled to announce that NeuroBionics has successfully raised $5 million in our latest funding round, a significant milestone that will propel our mission to revolutionize bioelectronic medicine. As pioneers in the field, we are dedicated to developing next-generation implantable devices that are designed to seamlessly interface with the human body. Our patented technology features flexible, multifunctional fibers the size of a human hair, capable of recording and stimulating neural activity, delivering drugs, and ablation of tissue. This innovative approach allows us to navigate microscopic-sized implants through the intricate network of blood vessels using a minimally-invasive endovascular technique, which holds the potential to transform deep brain stimulation therapies. With this fresh influx of capital, we are poised to expedite our research and development efforts, bringing us one step closer to offering accessible, lifechanging therapies for millions suffering from conditions such as Parkinson's disease, essential tremor, epilepsy, and depression. This funding reaffirms investor confidence in our vision and underscores the importance of accessible treatment solutions. We are excited to take this crucial step forward and are committed to enhancing the quality of life for individuals facing debilitating neurological challenges. Stay tuned as we embark on this transformative journey, leading us toward a future where neurotherapeutics are less invasive, more effective, and widely accessible.









